Παραπομπή APA

Rasmussen, M. F. (2020). The development of oral semaglutide, an oral GLP-1 analog, for the treatment of type 2 diabetes. Diabetol Int.

Παραπομπή Chicago Style

Rasmussen, Mads Frederik. "The Development of Oral Semaglutide, an Oral GLP-1 Analog, for the Treatment of Type 2 Diabetes." Diabetol Int 2020.

Παραπομπή MLA

Rasmussen, Mads Frederik. "The Development of Oral Semaglutide, an Oral GLP-1 Analog, for the Treatment of Type 2 Diabetes." Diabetol Int 2020.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.